Since platinum reduces the intracellular NAD+ and NADH pool and weakens CtBP-mediated repression of DDR genes, which fundamentally causes drug resistance in cancer cells, we provide evidence validating the hypothesis that metformin reverses the decrease in the NAD+/NADH ratio caused by platinum and improves drug sensitivity in OC cells. This evidence concerns the gene CTBP1 and cancer.